BioSpace News Archive

Syndax Pharmaceuticals, Inc. announced three presentations at the upcoming 2020 American Association for Cancer Research Virtual Annual Meeting being held April 27 - 28, 2020.

The n-Lorem Foundation announced it has received a pledge of $500,000 from Paul and Andrea Compton in support of the n-Lorem Foundation’s efforts to provide advanced, experimental RNA-targeted medicines free of charge for life to patients living with ultra-rare diseases.

LifeMax Laboratories, Inc. announced that the Food and Drug Administration granted fast track designation to LM-030, an investigational therapy licensed from Novartis and currently in a Phase 2/3 pivotal clinical trial for the treatment of Netherton Syndrome.

Natera, Inc. announced that it has priced $250 million aggregate principal amount of convertible senior notes due 2027.

Immutep Limited announced that interim Phase II TACTI-002 clinical data has been selected for a poster short talk presentation as part of the high-impact paper presentation program at the American Association for Cancer Research Virtual Annual Meeting, scheduled for 27 and 28 April.

Innate Pharma will hold its Annual General Meeting of Shareholders on May 19, 2020 AM in its headquarters, 117 avenue de Luminy, F-13009 Marseille.

Rapid access to pathology test results is critical to high quality and efficient modern healthcare. Advantages of rapid access to test results have been demonstrated in relation to patient length of stay in emergency departments and timeliness of access to information is critical for patient care decisions – such as for therapeutic drug monitoring and patient flow decisions.

Adamantane is class of antiviral drug which acts on influenza A virus (RNA Virus) and not on influenza B virus

Ampoules are the most widely used common packaging solutions globally. They are small sealed vials used to preserve samples in both liquid and solid forms.

Alliance Design Development Group (ADDG), an assistive human augmentation technology company known for creating SelectFlex® adjustable arch orthotics, donates 10% of sales to Global Giving and becomes ergonomic vendor for Roche subsidiary Genentech.